Kaohsiung Medical University Chung-Ho Memorial Hospital: Hepatitis C, Chronic trials

The registry lists 11 Hepatitis C, Chronic studies with Kaohsiung Medical University Chung-Ho Memorial Hospital as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 3 2Phase 4 6No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Nation-wide Hepatitis C Virus (HCV) Registry in TaiwanRecruitingNCT03200379
• Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination TherapyCompletedNCT02060058Phase 3Results posted
• 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild FibrosisCompletedNCT03186365Phase 3
• Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based TreatmentStatus unknownNCT03042520
• Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular CarcinomaStatus unknownNCT00834860Phase 4
• NIDDM and IR in Combination Therapy for CHCCompletedNCT00687999Not applicable
• Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 PatientsCompletedNCT00680173Phase 4
• Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular CarcinomaCompletedNCT00630084Phase 4
• A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 PatientsCompletedNCT00629967Phase 4
• Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis CCompletedNCT00629824Phase 4
• Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis CCompletedNCT00540345Phase 4